Papers
18
Total Citations
358
H-Index
9
About
Ciro Imbimbo is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for prostate and kidney cancers. His major contributions lie in evaluating the efficacy and safety of robot-assisted surgery for complex cases. He led a landmark systematic review and meta-analysis of over 6,500 cases, demonstrating the benefits of robotic simple prostatectomy for large benign prostatic hyperplasia (63 citations). His research also systematically assessed robot-assisted partial nephrectomy for challenging renal tumors, including large, endophytic, and hilar masses (55 citations). Imbimbo has explored novel biomarkers like 8-OHdG and 8-IsoPGF2α to measure oxidative stress following robotic radical prostatectomy (47 citations) and has investigated the role of multiparametric MRI in improving prostate cancer detection (47 citations). His work comparing percutaneous ablation to robotic partial nephrectomy for completely endophytic renal masses (40 citations) provides crucial guidance for treatment selection. With over 300 total citations, Imbimbo’s research directly informs clinical decision-making, helping surgeons optimize outcomes for patients with complex urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10